All articles tagged with #alt
Novo Nordisk signaled a bigger M&A push and ambitions for more than five obesity blockbusters by 2030, a plan that led to a share drop for Novo while lifting smaller obesity-focused names VKTX, GPCR and ALT on expectations of deal activity and partnerships.
A non-peer-reviewed Epic Research analysis of about 11,000 adults aged 18–44 found that lower AST (<14 U/L) and ALT (<14 U/L) levels were associated with a higher likelihood of early-onset colorectal cancer (65% and 68% higher, respectively), while higher AST/ALT were linked to a lower risk. The study is observational, does not establish causation or change screening guidelines (average-risk screening starts at 45), and researchers stress this is exploratory and warrants further investigation. No other routine labs showed an association.